Nuclear FGF-2 facilitates cell survival in vitro and during establishment of metastases

Oncogene

Volumn 23, Issue 27, 2004, Pages 4771-4779

  Thomas Mudge, Rachel J ^a   Okada Ban, Maï ^a   Vandenbroucke, Franck ^a   Vincent Salomon, Anne ^b   Girault, Jeanne Marie ^a   Thiery, Jean Paul ^a   Jouanneau, Jacqueline ^a  

^a INSTITUT CURIE   (France)

^b INSTITUT CURIE   (France)

Author keywords

Apoptosis; Metastases; Nuclear FGF 2; Survival

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; ISOPROTEIN; NUCLEAR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER MODEL; CARCINOMA CELL; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EXTRAVASATION; FEMALE; FLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SERUM; TUMOR PROMOTION; ANIMAL; BLADDER TUMOR; CANCER TRANSPLANTATION; CELL CLONE; CHEMISTRY; GENETICS; LUNG TUMOR; METABOLISM; MOLECULAR WEIGHT; PATHOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR CELL LINE; WESTERN BLOTTING; XENOGRAFT;

ANIMALIA; MUS MUSCULUS;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL NUCLEUS; CELL SURVIVAL; CLONE CELLS; FEMALE; FIBROBLAST GROWTH FACTOR 2; INJECTIONS, SUBCUTANEOUS; LUNG NEOPLASMS; MICE; MICE, NUDE; MOLECULAR WEIGHT; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PROTEIN ISOFORMS; RATS; TRANSPLANTATION, HETEROLOGOUS; URINARY BLADDER NEOPLASMS;

EID: 2942756041     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207638     Document Type: Article

References (38)

1. Al-Mehdi AB, Tozawa K, Fisher AB, Shientag L, Lee A and Muschel RJ. (2000). Nat. Med., 6, 100-102.
2. Arnaud E, Touriol C, Boutonnet C, Gensac MC, Vagner S, Prats H and Prats AC. (1999). Mol. Cell. Biol., 19, 505-514.
3. Boelaert K, McCabe CJ, Tannahill LA, Gittoes NJ, Holder RL, Watkinson JC, Bradwell AR, Sheppard MC and Franklyn JA. (2003). J. Clin. Endocrinol. Metab., 88, 2341-2347.
4. Bold RJ, Virudachalam S and McConkey DJ. (2001). Cancer, 92, 1122-1129.
5. Bugler B, Amalric F and Prats H. (1991). Mol. Cell. Biol., 11, 573-577.
6. Cameron MD, Schmidt EE, Kerkvliet N, Nadkarni KV, Morris VL, Groom AC, Chambers AF and MacDonald IC. (2000). Cancer Res., 60, 2541-2546.
7. Chao DT and Korsmeyer SJ. (1998). Annu. Rev. Immunol., 16, 395-419.
8. Delrieu I. (2000). FEBS Lett., 468, 6-10.
9. Farina KL, Wyckoff JB, Rivera J, Lee H, Segall JE, Condeelis JS and Jones JG. (1998). Cancer Res., 58, 2528-2532.
10. Fukui S, Nawashiro H, Otani N, Ooigawa H, Nomura N, Yano A, Miyazawa T, Ohnuki A, Tsuzuki N, Katoh H, Ishihara S and Shima K. (2003). Cancer, 97, 3061-3067.
11. Fukui S, Otani N, Nawashiro H, Yano A, Miyazawa T, Ohnuki A, Tsuzuki N, Katoh H, Ishihara S, Suzuki T and Shima K. (2002). J. Neurooncol., 57, 221-229.
12. Funato N, Moriyama K, Shimokawa H and Kuroda T. (1997). Biochem. Biophys. Res. Commun., 240, 21-26.
13. Gaubert F, Escaffit F, Bertrand C, Korc M, Pradayrol L, Clemente F and Estival A. (2001). J. Biol. Chem., 276, 1545-1554.
14. Giavazzi R, Giuliani R, Coltrini D, Bani MR, Ferri C, Sennino B, Tosatti MP, Stoppacciaro A and Presta M. (2001). Cancer Res., 61, 309-317.
15. Gossen M and Bujard H. (1992). Proc. Natl. Acad. Sci. USA, 89, 5547-5551.
16. Gualandris A, Arese M, Shen B and Rifkin DB. (1999). J. Cell. Physiol., 181, 273-284.
17. Hajihosseini MK and Dickson C. (1999). Mol. Cell. Neurosci., 14, 468-485.
18. Karsan A, Yee E, Poirier GG, Zhou P, Craig R and Harlan JM. (1997). Am. J. Pathol., 151, 1775-1784.
19. Konig A, Menzel T, Lynen S, Wrazel L, Rosen A, Al-Katib A, Raveche E and Gabrilove JL. (1997). Leukemia, 11, 258-265.
20. Koop S, MacDonald IC, Luzzi K, Schmidt EE, Morris VL, Grattan M, Khokha R, Chambers AF and Groom AC. (1995). Cancer Res., 55, 2520-2523.
21. Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, Chambers AF and Groom AC. (1998). Am. J. Pathol., 153, 865-873.
22. Maloof P, Wang Q, Wang H, Stein D, Denny TN, Yahalom J, Fenig E and Wieder R. (1999). Breast Cancer Res. Treat., 56, 153-167.
23. Miyake H, Hara I, Yamanaka K, Gohji K, Arakawa S and Kamidono S. (1999). Br. J. Cancer, 79, 1651-1656.
24. Naumov GN, Wilson SM, MacDonald IC, Schmidt EE, Morris VL, Groom AC, Hoffman RM and Chambers AF. (1999). J. Cell Sci., 112, 1835-1842.
25. Okada-Ban M, Moens G, Thiery JP and Jouanneau J. (1999). Oncogene, 18, 6719-6724.
26. Okada-Ban M, Thiery JP and Jouanneau J. (2000). Int. J. Biochem. Cell. Biol., 32, 263-267.
27. Pardo OE, Arcaro A, Salerno G, Raguz S, Downward J and Seckl MJ. (2002). J. Biol. Chem., 211, 12040-12046.
28. Pardo OE, Lesay A, Arcaro A, Lopes R, Ng BL, Warne PH, McNeish IA, Tetley TD, Lemoine NR, Mehmet H, Seckl MJ and Downward J. (2003). Mol. Cell. Biol., 23, 7600-7610.
29. Powers CJ, McLeskey SW and Wellstein A. (2000). Endocr. Relat. Cancer, 7, 165-197.
30. Rosini P, Bonaccorsi L, Baldi E, Chiasserini C, Ford G, De Chiara G, Lucibello M, Mongiat M, Iozzo RV, Garaci E, Cozzolino F and Torcia MG. (2002). Prostate, 53, 310-321.
31. Savagner P, Valles AM, Jouanneau J, Yamada KM and Thiery JP. (1994). Mol. Cell. Biol., 5, 851-862.
32. Sun G, Doble BW, Sun JM, Fandrich RR, Florkiewicz R, Kirshenbaum L, Davie JR, Cattini PA and Kardami E. (2001). J. Cell. Physiol., 186, 457-467.
33. Takaoka A, Adachi M, Okuda H, Sato S, Yawata A, Hinoda Y, Takayama S, Reed JC and Imai K. (1997). Oncogene, 14, 2971-2977.
34. Toyoshima K, Ito N, Hiasa Y, Kamamoto Y and Makiura S. (1971). J. Natl. Cancer Inst., 47, 979-985.
35. Van den Berghe L, Laurell H, Huez I, Zanibellato C, Prats H and Bugler B. (2000). Mol. Endocrinol., 14, 1709-1724.
36. Wert MM and Palfrey HC. (2000). Biochem. J., 352 (Part 1), 175-182.
37. Wieder R, Wang H, Shirke S, Wang Q, Menzel T, Feirt N, Jakubowski AA and Gabrilove JL. (1997). Growth Factors, 15, 41-60.
38. Wong CW, Lee A, Shientag L, Yu J, Dong Y, Kao G, Al-Mehdi AB, Bernhard EJ and Muschel RJ. (2001). Cancer Res., 61, 333-338.